- Home
- SEV vs FBIO Comparison
SEV vs FBIO Comparison
Compare SEV & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEV | FBIO |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | United States | United States |
| Employees | 46 | 78 |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.2M | 91.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SEV | FBIO |
|---|---|---|
| Price | $2.17 | $3.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 219.1K | ★ 441.6K |
| Earning Date | 05-16-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $55.22 |
| Revenue Next Year | $17,757.14 | $40.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.29 | $1.75 |
| 52 Week High | $11.24 | $4.53 |
Technical Indicators
Market Signals| Indicator | SEV | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | 65.96 |
| Support Level | $1.97 | $2.96 |
| Resistance Level | $3.26 | $3.89 |
| Average True Range (ATR) | 0.14 | 0.17 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 50.27 | 85.38 |
Price Performance
Historical ComparisonAbout SEV Aptera Motors Corp.
Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.